Celldom is a startup based in the United States.
Celldom develops a live single-cell biology platform that enables real-time, high-throughput analysis of cellular morphology, phenotypes, activity, and molecular profiles to facilitate drug screening and cellular research.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.